Eliem Therapeutics Inc (NASDAQ: ELYM) Stock Information | RedChip

Eliem Therapeutics Inc (NASDAQ: ELYM) Listen to this Section


$6.09
N/A ( 0% ) 124.0K

Eliem Therapeutics Inc is a clinical-stage biotechnology company. It is focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems. Its main drug candidate is ETX-155 for major depressive disorder (MDD) and focal onset seizures (FOS).

Market Data


Open


$6.09

Previous close


$6.09

Volume


124.0K

Market cap


$412.42M

Day range


$5.93 - $6.26

52 week range


$2.35 - $11.55

Insider Ownership Transactions

Total Amount Purchased: 813,670.00 | $ 4,955,250.30

Date Type Amount Purchased Purchaser
2024-07-23 Sale -10201.00 Morisset Valerie
2024-07-19 Sale -3207.00 Morisset Valerie
2024-07-17 Sale -50000.00 Morisset Valerie
2024-07-16 Sale -50000.00 Morisset Valerie
2024-07-11 Sale -5931.00 Morisset Valerie
2024-07-09 Sale -12342.00 Morisset Valerie
2024-07-03 Sale -7649.00 Morisset Valerie
2024-07-01 Buy 973000.00 RA CAPITAL MANAGEMENT, L.P.
2024-06-28 Sale -10000.00 Ratcliffe Liam
2024-06-28 Sale -10000.00 Rosenberg Adam Joseph

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 13 Aug 14, 2024
10-q Quarterly Reports 69 Aug 14, 2024
4 Insider transactions 1 Jul 23, 2024
4 Insider transactions 1 Jul 19, 2024
4 Insider transactions 1 Jul 17, 2024
4 Insider transactions 1 Jul 16, 2024
4 Insider transactions 1 Jul 11, 2024
4 Insider transactions 1 Jul 09, 2024
4 Insider transactions 1 Jul 03, 2024
4 Insider transactions 1 Jul 01, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.